Project Grant R03TR004982
Award Date 9/5/25
Completion Date 8/31/27
Dollars Obligated $155K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55414, USA
Similar Awards
- This federal Project Grant award from the Department of Health and Human Services National Institutes of Health Office of the Director provided $14,427,699 to New York University School of Medicine for the period of May 24, 2021 through May 23, 2022. The award was made under the Lung Diseases Research program (CFDA #93.838) to support the POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE: NYU LANGONE HEALTH CLINICAL SCIENCE CORE, DATA RESOURCE CORE, AND PASC BIOREPOSITORY CORE....
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $754,729 to the University of Pittsburgh to investigate the mechanisms by which respiratory viral infections, including COVID-19, can lead to persistent lung inflammation and damage. The research aims to understand how viral antigen persistence in pulmonary endothelial cells drives chronic activation of CD8+ T cells, leading to long-term pulmonary sequelae. The...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) provides $175,428 to The Trustees of the University of Pennsylvania to investigate the mechanisms and potential therapeutic targets for "Long COVID". The key objectives are to: 1) Determine how SARS-CoV-2-specific CD8 T cells respond to viral reservoirs in Long COVID patients, 2) Assess whether therapies that suppress SARS-CoV-2 replication...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $234,000.00 to Oregon Health & Science University (OHSU) to evaluate circulating viral and host microRNA (miRNA) signatures in SARS-CoV-2 infections. The project aims to shed light on miRNAs that can serve as systemic biomarkers to aid in stratifying patients and identifying those with active herpesvirus infections, such as Epstein-Barr virus (EBV), which have...
- The federal Project Grant award of $654,367.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, awarded on January 1, 2025, supports research to investigate the neural mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long COVID". The research aims to determine the relationship...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $639,740.00 to investigate the role of the CD38 enzyme in the development of chronic lung conditions following viral infections like COVID-19. The research aims to explore how targeting CD38 on CD8 tissue resident memory (TRM) cells could mitigate age-associated lung fibrosis after viral pneumonia. The award, effective December 15, 2024 through November 30, 2029, will support the lead researcher...
- This $198,720 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855, the Allergy and Infectious Diseases Research program, will fund a 5-year study to investigate post-infectious dysautonomia in patients with Post-Acute Sequelae of COVID-19 (PASC) and Post-Treatment Lyme Disease (PTLD). The Johns Hopkins University will leverage its clinical resources to prospectively evaluate patients, conduct objective autonomic testing, analyze...
- This $250,000 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Program (CFDA 93.855), will support the development of a structural causal framework for adaptive randomized clinical trials in infectious disease research. The project aims to address key methodological challenges in adaptive trials, such as unclear inferential targets, statistical biases from temporal and spatial variability,...
- The National Institute of Nursing Research (NINR) awarded Toivoa, Inc. a $383,159 Project Grant under the Nursing Research federal grant program (CFDA 93.361) to develop an accessible cognitive behavioral therapy (CBT) digital therapeutic for individuals with Long COVID. The project aims to address the critical and rapidly growing mental health needs of the over 100 million COVID-19 survivors in the U.S., up to 70% of whom experience long-term medical conditions and 10-20% develop Post-Acute...
- This Project Grant award of $2,549,080.00, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), supports research to investigate the impact of SARS-CoV-2 infection on the cerebrovasculature as a risk factor for vascular contributions to cognitive impairment and dementia (VCID). The award, with a performance period from August 11, 2025 to July 31, 2029, will fund the University of Illinois to: Determine how prior SARS-CoV-2 infection influences...